Sputum, Gotta Love The Stuff!

Similar documents
Chapter 9. Mucus-controlling Drug Therapy. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Disclaimer. Objectives. I can t cough it up! Airway Clearance Therapy. Heather Murgatroyd, RRT, RPSGT Field Clinical Specialist

The Acute & Maintenance Treatment of Asthma via Aerosolized Medications

Terminology. Terminology. Terminology. Mucus in Disease States. Mucus in Disease States. RSPT 2317 Mucoactive agents. RSPT 2217 Mucoactive Agents

National Horizon Scanning Centre. Mannitol dry powder for inhalation (Bronchitol) for cystic fibrosis. April 2008

CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions

The pharmacologic approach to airway clearance: Mucoactive agents

Bronchiectasis. Grant Waterer. Professor of Medicine, University of Western Australia Adjunct Professor of Medicine, Northwestern University, Chicago

4.6 Small airways disease

Overview of Cystic fibrosis in children. Apeksha Sathyaprasad, MD Pediatric pulmonologist

Worth Its SALT? Hypertonic Saline Revisited

Chronic Obstructive Pulmonary Disease (COPD) Copyright 2014 by Mosby, an imprint of Elsevier Inc.

The objectives of this presentation are to

Cystic Fibrosis. Jennifer McDaniel, BS, RRT-NPS

Dean R Hess PhD RRT FAARC

What is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF

A Place For Airway Clearance Therapy In Today s Healthcare Environment

Pulmo-Park Pom-Pom Shooter: Measuring the Effect of Restricted Breathing on Peak Expiratory Flow (PEF) Student Information Page Activity 5D

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs.

Focus on Cystic Fibrosis. Cystic Fibrosis. Cystic Fibrosis

Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review

MEDICAL POLICY. Proprietary Information of Excellus Health Plan, Inc. A nonprofit independent licensee of the BlueCross BlueShield Association

an inflammation of the bronchial tubes

PomPom SHOOTER. Activity Background: Common Obstructive Lung Disorders:

Protocol. Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Goals Basic defect Pathophysiology Clinical i l signs and symptoms Therapy

PATHOPHYSIOLOGICAL PROCESS TEMPLATE

Cystic Fibrosis the future

Chronic obstructive pulmonary disease

INHALED MUCOACTIVE DRUGS FOR TREATING NON-CYSTIC FIBROSIS BRONCHIECTASIS IN CHILDREN

Non Cystic Fibrosis Bronchiectasis: How to Proceed?

RESPIRATORY REHABILITATION

Section: Durable Medical Equipment Last Reviewed Date: June Policy No: 45 Effective Date: September 1, 2014

Bronchiectasis. Examples include: Viral infections (measles, adenovirus, influenza)

FEP Medical Policy Manual

COPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS

Life-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton

Levine Children s Hospital. at Carolinas Medical Center. Respiratory Care Department

Chapter 10 Respiration

Bronchiectasis. Introduction. Key points

Chronic obstructive lung disease. Dr/Rehab F.Gwada

Cystic fibrosis: From childhood to adulthood. Eitan Kerem Department of Pediatrics and CF Center Hadassah University Hospital Jerusalem Israel

Pharmacological airway clearance strategies in bronchiectasis

Lecture Notes. Chapter 3: Asthma

Integrated Cardiopulmonary Pharmacology Third Edition

Corporate Medical Policy

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

Respiratory Pharmacology: Treatment of Cystic Fibrosis

COPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES

COPD. Breathing Made Easier

COPD: Change in Definition. COPD Pathology with 3D Interactive. COPD: Definitions of 21st Century 1. COPD Includes Chronic Bronchitis 2

RESPIRATORY DISORDERS

Pulmonary Exacerbations:

Respiratory Anesthetic Emergencies in Oral and Maxillofacial Surgery. By: Lillian Han

COPD and Asthma: Similarities and differences Prof. Peter Barnes

BY BILL PRUITT, RRT, AE-C, CPFT, MBA, AND MICHAEL JACOBS, RN, CCRN, CEN, MSN

Over the last several years various national and

Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Role of mucolytics in the management of COPD

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness.

Clinical Commissioning Policy: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Chronic respiratory disease: towards better treatments

Treatment of Cough. Cough is a useful protective reflex. Cough is an indicator of an underlying illness.

Aerosol Therapy. Aerosol Therapy. RSPT 1410 Humidity & Aerosol Therapy Part 4

Pulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?

acapella vibratory PEP Therapy System Maximizing Therapy Effectiveness, Empowering Patient Compliance

Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis

High Frequency Chest Wall Oscillation Devices

Respiratory Management- Your Questions Answered! Michelle Chatwin, PhD Consultant Physiotherapist

Clinical Commissioning Policy Proposition: Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)

Citation for published version (APA): Schans, C. P. V. D. (1991). Physiotherapy and bronchial mucus transport s.n.

Medicine Dr. Kawa Lecture 1 Asthma Obstructive & Restrictive Pulmonary Diseases Obstructive Pulmonary Disease Indicate obstruction to flow of air

High Frequency Chest Wall Oscillating Devices (HFCWO) (Airway Clearance Systems)

The Use of Active Cycle of Breathing Technique (ACBT) In Pulmonary Physiotherapy: A Critical Review of the Literature Lauro G. Villegas Jr.

Effect of N-Acetylcysteine on Air Trapping in COPD. A Randomized Placebo-Controlled Study

Comparison of inhaled mannitol, daily rhdnase, and a combination. of both in children with cystic fibrosis: a randomised trial

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)

Mucolytics in cystic fibrosis

Mucomist Respirator Solution, Acetylcysteine USP 200 mg/ ml Solution for inhalation (not for injection)

10/05/2017. Learning Objectives. Etiology and Prevalence. Diagnosis of Cystic Fibrosis. Disease of Childhood? Survival in Cystic Fibrosis

TITLE: Hypertonic Saline Nebules for Patients with Cystic Fibrosis and Bronchioectasis: A Review of the Clinical and Cost-Effectiveness

Cystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina

Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus

The role of lung function testing in the assessment of and treatment of: AIRWAYS DISEASE

PDF of Trial CTRI Website URL -

Respiratory Therapy. Medical/Scientific/General Background

CYSTIC FIBROSIS OBJECTIVES NO CONFLICT OF INTEREST TO DISCLOSE

Physiotherapy in lung disease - top tips for clinicians. Sita Kansagra Specialist Outpatient Physiotherapist

Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis (Review)

CHAPTER 7.1 STRUCTURES OF THE RESPIRATORY SYSTEM

Lecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)

High Frequency Chest Wall Oscillation Devices

Active Cycle of Breathing Technique

Acapella versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial

Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions

Hyperinflation Therapy and the Tools to Accomplish It!! Bill Barnes, RN, RRT Good Shepherd Rehabilitation Network

Patient characteristics Intervention Comparison Length of followup

Non-CF bronchiectasis: Alexander Duarte, MD Pulmonary, Critical Care & Sleep Medicine University of Texas Medical Branch Galveston, TX

DISEASES OF THE RESPIRATORY SYSTEM 2018 DR HEYAM AWAD LECTURE 3: CHRONIC BRNCHITIS AND BRONCHIECTASIS

Transcription:

Sputum, Gotta Love The Stuff! Douglas S. Gardenhire, EdD, RRT-NPS, FAARC Associate Professor and Chairman Department of Respiratory Therapy Georgia State University

Objectives Differentiate mucus from sputum. Discuss factors associated with abnormal mucus production. Discuss diseases associated with abnormal mucus production. Discuss mucoactive agents. Discuss mucoactive treatments.

Overview What is mucus doing for me? Source Factors associated with mucus Mucus and disease vs. Sputum Physical Properties Mucoactive Agents Mucoactive Treatments

Mucociliary Escalator Major Defense mechanism Failure Obstruction Thickened adhesive secretions Slowed with disease

Mucus.Where and Why Airways Gastrointestinal tract Genital tract Protective Lubricating Waterproofing

Source of Airway Secretions Mucus Gel Layer Moved by cilia towards larynx Sol Layer Watery layer below gel layer Produced by Surface epithelial cells Goblet cells Submucosal glands

From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

Surface Epithelial Cells Surface of Trachea/bronchi Ciliated cells Goblet cells More than 6000 goblet cells per square mm of airway Responds only to irritants Submucosal Glands Produces most of mucus in airway Parasympathetic control Cholinergic Stimulation Possible Sympathetic Innervation

From Gardenhire, D. (2016). Rau s Respiratory Care Pharmacology, Elsevier

Factors Affecting Mucociliary Transport COPD CF Dry airway (dry gas from MV) Narcotics Suctioning; Trach Cigarette smoke Pollutants Hyperoxia and Hypoxia

Food Intake and Mucus Production Does milk or dairy increase mucus? NO No reason to withhold milk from patients with colds, RTI, or chronic disease Pinnock CB, etal Am Rev Respir Dis 141:352, 1990

Composition of Mucus 95% water 5% protein

Mucus and Disease Chronic Bronchitis Asthma Bronchorrhea Plastic Brochitis Cystic Fibrosis

Rogers D, Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007;52(9):1181

Chronic Bronchitis Clinically, daily X 3 mon; X 2yrs Hyperplasia goblet cells Goblet cells increase in number Submucosal glands hypertrophy Tobacco smoke; # 1 irritation factor Cause; mucus hypersecretion Associated with rapid decline in lung function Rubin BK, etal. Clin Pulm Med 5:1, 1998; Vestbo J, etal Am J Respir Crit Care Med 153:1530, 1996.

Asthma Hypersecretion can occur during exacerbation 80% of all patient report increased sputum Beta agonists on board- Problem? Beta agonists cause hypersecreation IV/Continuous nebulization Fatality? Turner-Warwick M. etal. Postgrad Med J 63(suppl 1):79, 1987. Rubin BK, Pediatr Pulmonol Suppl 23:88, 2001. Webber SE, etal. Agents Actions 22:82, 1987.

Bronchorrhea Clinically 100 ml of watery sputum daily Occurs in about 9% of asthmatics Treat with corticosteroids and/or antibiotics Shimura S, etal. Chest 94:1211, 1988; Marom ZM, etal. J Allergy Clin Immunol 87:1050, 1991.

Plastic Bronchitis Rare, Clinically, rigid airway casts Patients may cough up casts of the TB Tree May be toothpaste or pudding-like Madsen P, Shah SA, Rubin BK: Paediatr Respir Rev 6:292, 2005.

Cystic Fibrosis Chronic hereditary disease Impaired function of CFTR protein Chronic airway infection with Pseudomonas and other gram bacteria Chronic airway inflammation NO hypersecretion of airway Very little to no mucus in sputum Airway filled with PUS Similar sputum to bronchiectasis Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK: Chest 129:118, 2006.

Physical Properties of Mucus Mucus (low viscosity, high elasticity ) Sputum (viscosity increases) From Gardenhire, D. (2016)Rau s Respiratoy Care Pharmacology, Elsevier

Mucoactive Agents

N-ACETYL L-CYSTEINE (NAC) Reduce hepatic injury with acetaminophen overdose Long history of use No evidence of clinical efficacy Inhaled NAC can cause bronchospasm Breaks down mucus, not sputum Difference between mucus & sputum Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R et al.: Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial, Lancet 365 (9470): 1552-1560, 2005.

Rogers D, Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 2007;52(9):1181

Dornase Alfa (Pulmozyme) Reduces DNA and F-actin polymers Shak s, etal Proc Natl Acad Sci USA 98:9188, 1990 No efficacy in acute exacerbations No efficacy in non-cf bronchietasis Wilmott RW, etal Am J Respir Crit Care Med 153:1914, 1996 May decrease effectiveness of aminoglycosides Ramsey BW, etal Pediatr Pulmonol 17:404, 1994

Courtesy Bruce K. Rubin, From Gardenhire D, (2016) Rau s Respiratory Care Pharmacology, Elsevier

Expectorants

Iodide Containing Agents Supersaturated Potassium Iodide (SSKI) Stimulate airway fluid secretion Has failed to makes changes to PFT or sputum Rubin B, etal Chest 109:348, 1996

Sodium Bicarbonate Tracheal instillation or Inhalation 2% concentration Increases bronchial ph Breaks bonds, decreasing viscosity and elasticity Not clinically shown to increase mucus clearance From Gardenhire D, (2008) Rau s Respiratory Care Pharmacology, Mosby

Guaifenesin Can be toxic to cilia if directly applied Works by stimulation of submucosal gland Increases mucus production Not been demonstrated to be effective, clinically Rubin BK, etal. Chest 116:195, 1999

Mucus Why Protective Lubricating Waterproofing

Oligosaccharides Oligosaccharides side chains make up 80% of mucus Aerosolized low wt molecular heparin Used in treatment of asthma Interferes with antigen-receptor binding Disrupting H+ bond Same thought for use of aerosolized mannitol and dextran Ahmed T, etal. N Engl J Med 329:90, 1993

Mucokinetics

Bronchodilators Beta-agonists Produce mucus, can cause problems Mucus trapping, fatal asthma Work best by increasing airflow Newhouse, MT Euro J Respir Dis Suppl 124:151, 1983

Other

Hyperosmolar Saline 6% saline increased CF patients PFT Shown to improve PFTs in CF and non-cf bronchiectasis patients. Daviskas E. etal. Respirology 10:46, 2005 Mannitol has been effective in non-cf bronchiectasis patients Wills P, etal. Cochrane Database Syst Rev 3: CD001506, 2006 Not as effective as dornase alfa in CF Suri R, etal. Lancet 358:1316, 2001 Due to cough induction, aerosolized antibiotic therapy must be last!

Hypertonic Saline 7% hypertonic solution Commonly used in CF Believed to increase FEV1 by decreasing mucus Pulmosal FDA-cleared, buffered with sodium bicarbonate to a ph of 7.4. Others are acidic ph of 4.5 to 7.0 Pseudomonas aeruginosa has an affinity to colonize in an acidic ph of ~6.0.

PulmoSal vs. Hypertonic Saline

Mucoactive Therapy

Physiotherapy and Breathing Gravity Best if added to conventional CPT Mucus blanket can resist gravity alone GERD is a major problem Thomas J, etal. Am J Respir Crit Care Med 151:846, 1995 Breathing techniques Active cycle breathing (ACB) Diaphragmatic breathing with deep breaths Forced expiratory technique (FET) Huff cough with glottis open Hansani A, etal. Chest 105:1420, 1994 Exercise Increases sputum production Bilton, D, etal. Thorax 44:859, 1989

Insufflation-Exsufflation Stimulates cough with + and pressure Bach JR, Chest 105:1538, 1994

Positive Airway Pressure PEP Pursed lip breathing More effective than IS or IPPB Ricksten, SE, etal. Chest 89:774, 1986

Oscillation of the Airway Flutter Little research done 3 times more sputum in CF than cough or PD Konstan MW, etal. J Pediatr 124:689, 1994 Not confirmed or effective Homnick DN, etal. Chest 114:993, 1998 App EM, etal. Chest 114:171, 1998 Acapella Lung Flute Effective for sputum sampling Quake Generates vibrations on inhalation and exhalation

Lung Flute

Chest Wall Oscillation Vest Effective in CF Kluf J, etal. Pediatr Pulmonol 22:271, 1996 Not established in non-cf patients

HFCWO

Summary Difference between Mucus and Sputum Sputum becomes more viscid Mild does not thicken secretions A number of different solution available CPT is a gold standard Use exercise NAC does not work on pulmonary sputum Pulmozyme is only used for CF

Questions, Comments, Happy Thoughts? dgardenhire@gsu.edu